PharmaCyte Biotech (PMCB) Selling, General & Administrative (2010 - 2026)
PharmaCyte Biotech (PMCB) posted Selling, General & Administrative of $946,708 for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 25.7% from $753,148 a year earlier and up 5.2% from the prior quarter.
PharmaCyte Biotech (PMCB) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Selling, General & Administrative at PharmaCyte Biotech was $5.11 million, up 45.1% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $4.91 million, up 24.7% from FY2025.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 63.7% (FY2021 to FY2026).
- In prior fiscal years, PharmaCyte Biotech's Selling, General & Administrative was $3.94 million in FY2025 (-35.6%), $6.11 million in FY2024 (+449.4%), $1.11 million in FY2023 (+2.0%) and $1.09 million in FY2022 (+160.8%).
- Quarterly Selling, General & Administrative has run from a low of $183,043 in fiscal Q2 2023 to a high of $4.23 million in fiscal Q4 2024 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in five of the last eight quarters, with growth averaging 72.1%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q1 2024, with growth of 454.0%; the weakest was fiscal Q4 2025, with a decline of 78.4%.
- According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $899,882 (Q4 2026), $2.02 million (Q3 2026) and $1.23 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.19 Bn | 1,108.77 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 634.59 Bn | 554.45 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 499.62 Bn | 472.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.90 Bn | 309.28 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 300.00 Bn | 263.99 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 263.32 Bn | 237.01 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 238.09 Bn | 193.49 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 193.99 Bn | 168.19 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 170.34 Bn | 116.99 Bn | 10.94 Bn | 3.41 Bn |
| 10 | PharmaCyte Biotech | 3.67 Mn | -69.17 Mn | - | 946,708.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 946,708.00 |
| Apr 30, 2026 | 899,882.00 |
| Jan 31, 2026 | 2.02 Mn |
| Oct 31, 2025 | 1.23 Mn |
| Jul 31, 2025 | 753,148.00 |
| Apr 30, 2025 | 915,130.00 |
| Jan 31, 2025 | 842,056.00 |
| Oct 31, 2024 | 1.01 Mn |
| Jul 31, 2024 | 1.17 Mn |
| Apr 30, 2024 | 4.23 Mn |
| Jan 31, 2024 | 251,903.00 |
| Oct 31, 2023 | 272,517.00 |
| Jul 31, 2023 | 1.36 Mn |
| Apr 30, 2023 | 328,080.00 |
| Jan 31, 2023 | 356,885.00 |
| Oct 31, 2022 | 183,043.00 |
| Jul 31, 2022 | 244,669.00 |
| Apr 30, 2022 | 254,411.00 |
| Jan 31, 2022 | 215,315.00 |
| Oct 31, 2021 | 258,675.00 |
PharmaCyte Biotech Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();